What Life3 develops
Life3 Biotech Pte Ltd is a Singapore company that combines urban agriculture, biotechnology and food science to develop functional foods and beverages. Its about page describes the flagship product as a proprietary plant-based protein aimed at rising demand for sustainable, nutritionally optimised ingredients. The stated mission is to promote health and wellness and support Singapore’s food security.
The FAQ introduces Veego, a rich plant-based protein alternative made from a natural blend of whole foods including legumes, grains and mushrooms. It is described as high in protein and fibre, low in fat, and free from artificial colouring, flavouring and preservatives. Background on related ingredients is in the entries on pea protein and textured vegetable protein.
Life3 distinguishes itself from meat-analogue makers. The FAQ says most plant-based foods try to replace meat and focus on texture and taste, while Life3’s products are primarily functional. They are meant as a healthier alternative, and they are sold raw so that cooks can season and prepare them like raw meat.
Technology and expertise
The about page organises expertise in three areas. Agritech covers developing plant recipes and varieties to improve nutritional profile, redesigning cultivation systems to grow more with less, and improving the energy efficiency and circularity of urban farms. Biotech combines microbiology, biochemistry and bioprocessing for research, formulation and proof points for functional claims.
Foodtech focuses on applications such as flavours for ocean and meat alternatives, Asian-based flavours and functional fats for taste. The company also describes tools: machine learning to characterise an internal database of more than 200 plant samples and their bioactive ingredients, and proprietary bioprocessing capabilities that include microencapsulation, shear-cell technology and thermal pre-treatment.
Shear-cell technology is a route to fibrous texture, since it aligns proteins under controlled shear and heat. The innovations page says microencapsulation enhances the stability and dispersibility of selected bioactives. It also mentions work on ingredients that lower glycaemic response, a claim area that needs clinical support in every market.
Products and use
The innovations page describes versatile formats. Customers can create patties, sausage fillings and balls, or slice, strip, cube, mince and fillet the product, and cook it by stir-frying, deep-frying, grilling, boiling or braising. The range is presented as compatible with different food cultures, and as low in saturated fat and cholesterol, gluten-free and a good source of protein and fibre.
Life3 alternative proteins are formulated with 100% plant-based ingredients chosen for their nutritional profiles, including whole foods such as legumes and vegetables. The company says its products are natural, sustainable and versatile enough for a wide range of culinary preparation methods and food manufacturing applications. A manufacturer should ask which formats are sold to industry and which only reach consumers.
The website’s latest news item dates from May 2021, when an international investor joined the board, and the pages carry a 2019 copyright line. Because little recent information is published, any buyer should confirm directly that the products and facility described are operating, and ask for current specifications, certificates and delivery terms before including the material in a product plan.
What a buyer would check
Start by confirming what is available and in which form. The site mentions a proprietary protein as flagship and Veego as a finished product, but lists no technical datasheet. Ask for protein content, ingredient declaration, moisture, allergens and microbiological limits, and clarify whether the protein can be bought as an ingredient.
Regulatory and labelling topics follow. Legumes and mushrooms bring allergen and sensitisation questions, and functional or glycaemic claims require evidence in each jurisdiction. The company’s claims of higher nutritional value than meat and other meat alternatives should be backed by analytical reports before being repeated in marketing materials for customers.
Finally, assess continuity and scale. A small company’s capacity may be limited, and delivery terms may depend on a single site. Request audit reports, a description of the production facility, and references from customers, and plan trial lots before changing a recipe. A second supplier of comparable plant protein is a sensible safeguard until supply history is established.